Latest filing published 09 Dec 2025 for Akero Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Chou Judy on record concern Akero Therapeutics, Inc., in the capacity of senior executive. We count 2 filings; the first trade dates from 3 June 2025 and the latest from 9 December 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 9 December 2025: a transaction, in Akero Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.